Facility Evaluation Report

Licensing Program Analyst (LPA) Manuel Monter arrived unannounced to deliver the results of a complaint investigation 26-AS-20250812163239 . During the complaint investigation, a case management deficiencies visit was conducted due to violations discovered during the investigation process. LPA met with Wellness Director (WD) Trisa Cysewski and explained the purpose of the visit.

The Department reviewed R1’s July and August 2025 Medication Administration Record (MAR). Based on a review, the facility is recording R1’s blood glucose level twice daily. The MAR is also tracking the change in glucose monitoring sensor every 2 weeks.

The Department reviewed R1’s Physician’s Order Report, dated December 13, 2025. Based on a review R1’s glucose monitoring is scheduled to be completed daily at 5:00am and 5:00pm. R1’s glucose sensor is changed every 2 weeks.

On January 8, 2026, LPA Manuel Monter interviewed Administrator (ADM) April Princesa. ADM stated R1’s family member changes R1’s censors every 2 weeks. ADM stated the med tech will provide the new censor to R1’ son and will observe the changing of the censors and will mark it on the MAR. ADM stated Medtech’s check the blood sugar for R1 by using the glucose monitoring device and check the blood sugar, via the censor.